[go: up one dir, main page]

CN101486794B - Preparation method of high antibacterial activity ε-poly-L-lysine component - Google Patents

Preparation method of high antibacterial activity ε-poly-L-lysine component Download PDF

Info

Publication number
CN101486794B
CN101486794B CN200810153709XA CN200810153709A CN101486794B CN 101486794 B CN101486794 B CN 101486794B CN 200810153709X A CN200810153709X A CN 200810153709XA CN 200810153709 A CN200810153709 A CN 200810153709A CN 101486794 B CN101486794 B CN 101486794B
Authority
CN
China
Prior art keywords
poly
molecular weight
lysine
epsilon
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200810153709XA
Other languages
Chinese (zh)
Other versions
CN101486794A (en
Inventor
贾士儒
沈颜新
谭之磊
周斌
贾原媛
范宝庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHEJIANG SILVER-ELEPHANT BIO-ENGINEERING Co Ltd
Original Assignee
YINXIANG BIOLOGICAL ENGINEERING Co Ltd ZHEJIANG PROV
Tianjin University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YINXIANG BIOLOGICAL ENGINEERING Co Ltd ZHEJIANG PROV, Tianjin University of Science and Technology filed Critical YINXIANG BIOLOGICAL ENGINEERING Co Ltd ZHEJIANG PROV
Priority to CN200810153709XA priority Critical patent/CN101486794B/en
Publication of CN101486794A publication Critical patent/CN101486794A/en
Application granted granted Critical
Publication of CN101486794B publication Critical patent/CN101486794B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

本发明涉及一种高抑菌活性ε-聚-L-赖氨酸(ε-PL)组分的制备方法,是采用微虑、超滤和纳滤组合多级分离技术获取不同分子量分布的ε-PL,经抑菌实验确定最佳抑菌活性组分分子量范围,进而收集干燥获得高抑菌活性组分ε-PL产品。应用本发明的方法可以获得不同分子量范围的高纯度的ε-PL,由于采用的是膜分离技术,不会对ε-PL的活性产生任何影响,而且有利于各种不同分子量的ε-PL的研究。The present invention relates to a preparation method of ε-poly-L-lysine (ε-PL) component with high antibacterial activity, which adopts microfiltration, ultrafiltration and nanofiltration combined multistage separation technology to obtain ε with different molecular weight distributions -PL, through antibacterial experiments to determine the molecular weight range of the best antibacterial active components, and then collect and dry to obtain high antibacterial active component ε-PL products. Applying the method of the present invention can obtain high-purity ε-PL in different molecular weight ranges, because the membrane separation technology is used, it will not have any impact on the activity of ε-PL, and it is beneficial to the production of ε-PL with various molecular weights. Research.

Description

高抑菌活性ε-聚-L-赖氨酸组分的制备方法 Preparation method of high antibacterial activity ε-poly-L-lysine component

技术领域technical field

本发明属于生物化工技术领域,尤其是一种高抑菌活性ε-聚-L-赖氨酸组分的制备方法。The invention belongs to the technical field of biochemical industry, in particular to a preparation method of ε-poly-L-lysine component with high antibacterial activity.

背景技术Background technique

ε-聚-L-赖氨酸(ε-poly-L-lysine,简称ε-PL)是由白色链霉菌等菌种生物合成的一种氨基酸同型聚和物,是由单体L-赖氨酸的ε-氨基和另一单体L-赖氨酸的α-羧基形成的酰胺键连接而成。ε-PL水溶性好,微溶于乙醇,热稳定性高,抑菌谱广,能够抗革兰氏阳性菌、革兰氏阴性菌、真菌、耐热芽孢杆菌及病毒的活性,在人体内分解为L-赖氨酸。L-赖氨酸是人体必须的八种氨基酸之一,因此是一种安全高效的天然生物防腐剂。此外,ε-PL还可用做基因运输载体、药物包被材料、电子材料,环保材料等,具有十分广泛的应用前景。近年来,随着菌种性能的改造和发酵调控手段的改进,ε-PL的发酵生产效率不断的提高。ε-poly-L-lysine (ε-poly-L-lysine, referred to as ε-PL) is an amino acid homopolymer biosynthesized by Streptomyces albicans and other strains. The ε-amino group of the acid is connected with the amide bond formed by the α-carboxyl group of another monomer L-lysine. ε-PL has good water solubility, slightly soluble in ethanol, high thermal stability, broad antibacterial spectrum, and can resist the activity of Gram-positive bacteria, Gram-negative bacteria, fungi, heat-resistant bacillus and viruses. Break down into L-lysine. L-Lysine is one of the eight essential amino acids for the human body, so it is a safe and efficient natural biological preservative. In addition, ε-PL can also be used as a gene transport carrier, drug coating material, electronic material, environmental protection material, etc., and has a very wide application prospect. In recent years, with the improvement of strain performance and fermentation control means, the fermentation production efficiency of ε-PL has been continuously improved.

目前,我国公布的有关ε-PL生产的主要专利有:At present, the main patents related to the production of ε-PL published in my country are:

1.2000年7月12日,国家知识产权局公布了日本国岩田敏志等人在中国申请的名称为“大量产生ε-聚-L-赖氨酸的菌株和生产方法”的发明专利,专利号为97182253.0。此专利提供一种较常规的提高菌株ε-PL的生成能力以及大规模生产ε-PL的方法。1. On July 12, 2000, the State Intellectual Property Office announced the invention patent titled "Strain and Production Method for Large-scale Production of ε-poly-L-lysine" applied by Japan's Toshishi Iwata and others in China. The patent number is 97182253.0. This patent provides a relatively conventional method for improving the production capacity of strain ε-PL and producing ε-PL on a large scale.

2.2005年11月16日,国家知识产权局公布了由南京工业大学申请的“利用北里孢菌PL6-3制备ε-PL及其盐的方法”发明专利,申请号为200510037774.2。该专利提出了一种通过筛选获得的北里孢菌PL-3发酵生产ε-PL的方法。2. On November 16, 2005, the State Intellectual Property Office announced the invention patent of "Method for Preparing ε-PL and Its Salts Using Lispora militaris PL6-3" applied by Nanjing University of Technology, the application number is 200510037774.2. This patent proposes a method for producing ε-PL by fermenting PL-3 obtained from B. militaris through screening.

3.2007年11月28日,国家知识产权局公布了由申请人自己申请的“回流工艺生产ε-聚-L-赖氨酸的方法”发明专利,申请号为200610013800.2。该专利提出了一种回流工艺生产ε-PL的方法,即在ε-PL的发酵过程中,将提取过程的后期穿透液作为流加液,进行流加发酵生产ε-PL。后期穿透液作为流加液使用,提高了ε-PL的产率,减少了发酵废液和洗脱用盐酸废液的排放,减轻了环境兀然。2007年4月9日,申请人在已有专利的基础上继续申请了“一种大量产生ε-PL的诱变菌株白色链霉菌TUST2及利用该诱变菌株TUST2采用发酵法生产ε-PL及其盐的方法”的发明专利,申请号200710057098.4。该专利利用从我国海南省土壤中筛选、诱变并鉴定的ε-PL的生产菌株白色链霉菌TUST2(CGMCC No.1986)发酵生产ε-PL,产量在10~30g/L。3. On November 28, 2007, the State Intellectual Property Office announced the invention patent of "method for producing ε-poly-L-lysine by reflow process" applied by the applicant himself, and the application number is 200610013800.2. This patent proposes a method for producing ε-PL by a reflux process, that is, during the fermentation process of ε-PL, the breakthrough liquid in the later stage of the extraction process is used as a fed-in solution for fed-batch fermentation to produce ε-PL. The later breakthrough liquid is used as feed liquid, which improves the yield of ε-PL, reduces the discharge of fermentation waste liquid and hydrochloric acid waste liquid for elution, and reduces environmental pollution. On April 9, 2007, the applicant continued to apply for "a mutagenous strain Streptomyces albicans TUST2 that produces a large amount of ε-PL and uses the mutagenized strain TUST2 to produce ε-PL and The method of its salt", the invention patent, application number 200710057098.4. This patent utilizes Streptomyces albicans TUST2 (CGMCC No.1986), a production strain of ε-PL that was screened, mutated and identified from the soil in Hainan Province, my country, to ferment and produce ε-PL with a yield of 10-30 g/L.

已有研究表明,微生物发酵生产的ε-PL分子量分布范围较广,不同聚合度的ε-PL有着不同的理化性质和用途;另外,ε-PL分子量不同,它的抑菌效果有很大差别。Studies have shown that the molecular weight distribution of ε-PL produced by microbial fermentation is wide, and ε-PL with different degrees of polymerization has different physical and chemical properties and uses; in addition, the molecular weight of ε-PL is different, and its antibacterial effect is very different .

发明内容Contents of the invention

本发明的目的在于克服现有技术的不足,提供一种高抑菌活性ε-聚-L-赖氨酸组分的制备方法,该方法将现有工艺生产的ε-PL按照不同分子量(不同聚和度)进行分级处理,并收集具有高抑菌活性的ε-PL组分。The purpose of the present invention is to overcome the deficiencies in the prior art, to provide a kind of preparation method of high bacteriostatic activity epsilon-poly-L-lysine component, the epsilon-PL that this method produces according to existing technology according to different molecular weight (different Polymerization degree) was graded, and the ε-PL fraction with high antibacterial activity was collected.

本发明的技术方案是:Technical scheme of the present invention is:

一种高抑菌活性ε-聚-L-赖氨酸组分的制备方法,其制备方法的步骤是:A kind of preparation method of high bacteriostatic activity epsilon-poly-L-lysine component, the steps of its preparation method are:

(1).将ε-PL发酵液经离心去除菌体和蛋白后,通过脱色得到ε-PL滤液;(1). After centrifuging the ε-PL fermentation broth to remove bacteria and protein, obtain the ε-PL filtrate by decolorization;

(2).将ε-PL滤液加入到事先组装好的各种截留分子量的微滤、超滤和纳滤膜组合分离装置中,进行分离并分别获得各种分子量分布的ε-PL组分滤液;(2). Add the ε-PL filtrate to the pre-assembled microfiltration, ultrafiltration and nanofiltration membrane combination separation device with various molecular weight cut-offs, separate and obtain ε-PL component filtrates with various molecular weight distributions ;

(3).验证ε-PL滤液分子量范围在2KDa~5KDa内,并通过浓缩、低温冷冻干燥或喷雾干燥得到高抑菌活性的ε-PL产品。(3). Verify that the molecular weight of the ε-PL filtrate ranges from 2KDa to 5KDa, and obtain ε-PL products with high antibacterial activity through concentration, low-temperature freeze-drying or spray drying.

而且,所述滤膜的材质为聚砜、聚酰胺、细菌纤维素、再生纤维素或者其他适宜pH值在2~14的滤膜,其微滤膜的孔径为0.2μm,超滤和纳滤膜的截留分子量分别为25KDa、10kDa、5kDa、2kDa、1kDa,采用微滤、超滤和纳滤膜组合分离装置进行分离纯化。Moreover, the material of the filter membrane is polysulfone, polyamide, bacterial cellulose, regenerated cellulose or other filter membranes with a suitable pH value of 2 to 14, the pore size of the microfiltration membrane is 0.2 μm, ultrafiltration and nanofiltration The molecular weight cut-offs of the membranes are 25KDa, 10kDa, 5kDa, 2kDa, and 1kDa, respectively. Microfiltration, ultrafiltration and nanofiltration membrane combination separation devices are used for separation and purification.

而且,所述过滤分级处理的工作压力可在0.05~1.0MPa,发酵液过滤的pH为中性,温度为20~40℃。Moreover, the working pressure of the filtration and classification treatment can be 0.05-1.0 MPa, the pH of the fermentation broth filtration is neutral, and the temperature is 20-40°C.

本发明的优点和积极效果是:Advantage and positive effect of the present invention are:

本发明对ε-聚-L-赖氨酸按分子量大小进行膜组合技术分级处理,通过抑菌实验来确定具有高抑菌活性的分子量部分,从而制备具有高抑菌活性的合适分子量分布的ε-聚-L-赖氨酸产品。应用本发明的方法可以获得不同分子量范围的高纯度的ε-PL滤液,由于采用的是膜分离技术,不会对ε-PL的活性产生任何影响,而且有利于各种不同分子量的ε-PL的研究。In the present invention, ε-poly-L-lysine is graded according to the molecular weight of the membrane combination technology, and the molecular weight part with high bacteriostatic activity is determined through antibacterial experiments, so as to prepare ε with a suitable molecular weight distribution with high bacteriostatic activity. - Poly-L-lysine products. Applying the method of the present invention can obtain high-purity ε-PL filtrates in different molecular weight ranges, because the membrane separation technology is used, it will not have any impact on the activity of ε-PL, and it is beneficial to the ε-PL of various molecular weights Research.

具体实施方式Detailed ways

下面结合实施例对本发明进一步说明;下述实施例是说明性的,不是限定性的,不能以下述实施例来限定本发明的保护范围。The present invention is further described below in conjunction with embodiment; Following embodiment is illustrative, not limiting, can not limit protection scope of the present invention with following embodiment.

需要说明的是,本发明发酵液是按照“回流工艺生产ε-聚-L-赖氨酸的方法”专利中的方法制备的,所用菌种为“一种大量产生ε-PL的诱变菌株白色链霉菌TUST2及利用该诱变菌株TUST2采用发酵法生产ε-PL及其盐的方法”专利中的菌种。It should be noted that the fermentation broth of the present invention is prepared according to the method in the patent "Method for producing ε-poly-L-lysine by reflux process", and the strain used is "a mutagenized strain that produces a large amount of ε-PL Streptomyces albicans TUST2 and the method for producing ε-PL and its salts by fermentation using the mutagenized strain TUST2" are strains in the patent.

本发明所用滤膜的材质可以为聚砜、聚酰胺、细菌纤维素、再生纤维素或者其他适宜pH值在2~14的滤膜,微滤膜的孔径为0.2μm,超滤和纳滤膜的截留分子量分别为25KDa、10kDa、5kDa、2kDa、1kDa,采用微滤、超滤和纳滤膜组合分离装置进行分离纯化。The material of the filter membrane used in the present invention can be polysulfone, polyamide, bacterial cellulose, regenerated cellulose or other filter membranes with a suitable pH value of 2 to 14, the pore size of the microfiltration membrane is 0.2 μm, ultrafiltration and nanofiltration membranes The molecular weight cut-offs are 25KDa, 10kDa, 5kDa, 2kDa, 1kDa, respectively, and are separated and purified by a combination of microfiltration, ultrafiltration and nanofiltration membrane separation devices.

本发明过滤分级处理的工作压力可在0.05~1.0MPa,发酵液过滤的pH为中性,温度为25℃。The working pressure of the filtration and classification treatment of the present invention can be 0.05-1.0 MPa, the pH of fermentation broth filtration is neutral, and the temperature is 25 DEG C.

本发明收集抑菌活性最高的分子量段为2KDa~5KDa的ε-PL溶液,经喷雾干燥或冷冻干燥制成ε-PL产品,用做食品防腐剂。The invention collects the ε-PL solution with the highest antibacterial activity and the molecular weight range of 2KDa to 5KDa, and sprays or freezes it to make the ε-PL product, which is used as a food preservative.

下面给出本发明的实施例:Provide the embodiment of the present invention below:

实施例1:Example 1:

含量20g/L ε-PL发酵液离心分离菌体,经脱色后所得溶液即可进行膜组合分离装置分离。Content 20g/L ε-PL fermentation broth was centrifuged to separate bacteria, and the solution obtained after decolorization could be separated by membrane combination separation device.

取2000ml ε-PL滤液,逐级经过0.2μm微滤膜、25KDa、10KDa、5KDa、2KDa,1KDa超滤膜和纳滤膜。其中微滤的操作压力为0.05MPa,截留分子量为25KDa、10KDa、5KDa的超滤膜的操作压力为0.15MPa,截留分子量为2KDa的超滤膜的操作压力为0.2MPa,1KDa的纳滤膜的操作压力为0.7MPa。Take 2000ml ε-PL filtrate and pass through 0.2μm microfiltration membrane, 25KDa, 10KDa, 5KDa, 2KDa, 1KDa ultrafiltration membrane and nanofiltration membrane step by step. Among them, the operating pressure of microfiltration is 0.05MPa, the operating pressure of ultrafiltration membrane with molecular weight cut off of 25KDa, 10KDa and 5KDa is 0.15MPa, the operating pressure of ultrafiltration membrane with molecular weight cut off of 2KDa is 0.2MPa, and the operating pressure of ultrafiltration membrane with molecular weight cut off of 1KDa is 0.2MPa. The operating pressure is 0.7MPa.

微滤膜对ε-PL滤液的截留率为0,透过液体积约为2000ml;通过25KDa超滤膜之后,透过液与浓缩液的体积比约为10:1;通过10KDa超滤膜之后,透过液与截留液的体积比约为7:1;通过5KDa超滤膜之后,透过液与截留液的体积比约为7:1;通过2KDa超滤膜之后,透过液与截留液的体积比约为2:1;最后通过1KDa纳滤膜之后,透过液与浓缩液的体积比约为1:1。The rejection rate of the microfiltration membrane to ε-PL filtrate is 0, and the volume of the permeate is about 2000ml; after passing through the 25KDa ultrafiltration membrane, the volume ratio of the permeate to the concentrate is about 10:1; after passing through the 10KDa ultrafiltration membrane , the volume ratio of the permeate to the retentate is about 7:1; after passing through the 5KDa ultrafiltration membrane, the volume ratio of the permeate to the retentate is about 7:1; after passing through the 2KDa ultrafiltration membrane, the ratio of the permeate to the retentate The volume ratio of the liquid is about 2:1; after finally passing through the 1KDa nanofiltration membrane, the volume ratio of the permeate to the concentrate is about 1:1.

然后针对各个不同组分做抑菌实验。Then antibacterial experiments were carried out for each of the different components.

通过抑菌实验验证的结果(见附表1),得出抑菌效果最好的分子量段为2KDa~5KDa,收集这一部分的溶液,进行浓缩经冷冻干燥制成高抑菌活性ε-PL产品。Through the results of antibacterial experiment verification (see attached table 1), it is concluded that the molecular weight segment with the best antibacterial effect is 2KDa ~ 5KDa. This part of the solution is collected, concentrated and freeze-dried to make a high antibacterial activity ε-PL product .

实施例2:Example 2:

ε-PL产品粉末配置成20g/L溶液2L(pH为中性,温度为25℃),再依次通过微滤、超滤和纳滤组合膜分离装置进行膜过滤分离。其中微滤的操作压力为0.1MPa,截留分子量为25KDa、10KDa、5KDa的超滤膜的操作压力为0.2MPa,截留分子量为2KDa的超滤膜的操作压力为0.25MPa,1KDa的纳滤膜的操作压力为1MPa。The ε-PL product powder is prepared into 2L of 20g/L solution (pH is neutral, temperature is 25°C), and then separated by membrane filtration through microfiltration, ultrafiltration and nanofiltration combined membrane separation device in sequence. Among them, the operating pressure of microfiltration is 0.1MPa, the operating pressure of ultrafiltration membrane with molecular weight cut off of 25KDa, 10KDa and 5KDa is 0.2MPa, the operating pressure of ultrafiltration membrane with molecular weight cut off of 2KDa is 0.25MPa, and the operating pressure of ultrafiltration membrane with molecular weight cut off of 1KDa is 0.25MPa. The operating pressure is 1MPa.

上述2000ml的ε-PL溶液完全透过微滤膜;之后,通过25KDa超滤膜,透过液与截留液的体积比约为10:1;再通过10KDa超滤膜,透过液与截留液的体积比约为8:1;然后通过5KDa超滤膜之后,透过液与截留液的体积比约为7:1;接着通过2KDa超滤膜,透过液与截留液的体积比约为2:1;最后通过1KDa纳滤膜之后,透过液与截留液的体积比约为1:1。The above 2000ml ε-PL solution completely permeated the microfiltration membrane; after that, it passed through the 25KDa ultrafiltration membrane, and the volume ratio of the permeate to the retentate was about 10:1; then passed through the 10KDa ultrafiltration membrane, the permeate to the retentate The volume ratio of the permeate to the retentate is about 8:1; then after passing through the 5KDa ultrafiltration membrane, the volume ratio of the permeate to the retentate is about 7:1; then through the 2KDa ultrafiltration membrane, the volume ratio of the permeate to the retentate is about 2:1; after finally passing through the 1KDa nanofiltration membrane, the volume ratio of the permeate to the retentate is about 1:1.

然后针对各个不同组分做抑菌实验。Then antibacterial experiments were carried out for each of the different components.

通过抑菌实验结果,即可得出抑菌效果最好的分子量段为2KDa~5KDa,收集这一部分的溶液,进行浓缩后经冷冻干燥制成高抑菌活性ε-PL产品。According to the results of antibacterial experiments, it can be concluded that the molecular weight segment with the best antibacterial effect is 2KDa ~ 5KDa. This part of the solution is collected, concentrated and then freeze-dried to produce a high antibacterial activity ε-PL product.

表1Table 1

Figure G200810153709XD00041
Figure G200810153709XD00041

Claims (2)

1. the preparation method of a high bacteriostatic activity epsilon-poly-L-lysine component, it is characterized in that: preparation method's step is:
(1). epsilon-poly-L-lysine ε-PL fermented liquid behind centrifugal removal thalline and albumen, is obtained ε-PL filtrate by decolouring;
(2). epsilon-poly-L-lysine ε-PL filtrate is joined in micro-filtration, ultrafiltration and the nanofiltration membrane combination tripping device of the various molecular weight cut-offs that assemble in advance, separate and obtain respectively the ε-PL component filtrate of various molecular weight distribution;
(3). checking epsilon-poly-L-lysine ε-PL filtrate molecular weight ranges is in 2KDa~5KDa, and by the ε-PL product that concentrates, frozen drying or spraying drying obtain high bacteriostatic activity;
The material of described filter membrane is polysulfones, polymeric amide, bacteria cellulose, regenerated cellulose or other appropriate pH values at 2~14 filter membrane, the aperture of its microfiltration membrane is 0.2 μ m, the molecular weight cut-off of ultrafiltration and nanofiltration membrane is respectively 25KDa, 10kDa, 5kDa, 2kDa, 1kDa, adopts micro-filtration, ultrafiltration and nanofiltration membrane combination tripping device to carry out separation and purification.
2. the preparation method of high bacteriostatic activity epsilon-poly-L-lysine component according to claim 1 is characterized in that: the operating pressure of described filtration stage treatment is at 0.05~1.0Mpa, and the pH of filtering fermentation liquor is neutral, and temperature is 20~40 ℃.
CN200810153709XA 2008-12-03 2008-12-03 Preparation method of high antibacterial activity ε-poly-L-lysine component Active CN101486794B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810153709XA CN101486794B (en) 2008-12-03 2008-12-03 Preparation method of high antibacterial activity ε-poly-L-lysine component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810153709XA CN101486794B (en) 2008-12-03 2008-12-03 Preparation method of high antibacterial activity ε-poly-L-lysine component

Publications (2)

Publication Number Publication Date
CN101486794A CN101486794A (en) 2009-07-22
CN101486794B true CN101486794B (en) 2010-11-17

Family

ID=40889866

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810153709XA Active CN101486794B (en) 2008-12-03 2008-12-03 Preparation method of high antibacterial activity ε-poly-L-lysine component

Country Status (1)

Country Link
CN (1) CN101486794B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105778118B (en) * 2016-03-30 2018-09-28 浙江新银象生物工程有限公司 A kind of preparation method of epsilon-polylysine
CN106380592B (en) * 2016-11-04 2018-10-16 江南大学 A method of extracting epsilon-polylysine and its hydrochloride from zymotic fluid
CN111777760A (en) * 2020-07-03 2020-10-16 中国科学院过程工程研究所 A kind of ε-polylysine separation and purification process and application
CN112237844A (en) * 2020-10-28 2021-01-19 江南大学 A kind of method for improving high polymerization degree ε-polylysine in product

Also Published As

Publication number Publication date
CN101486794A (en) 2009-07-22

Similar Documents

Publication Publication Date Title
CN103224571B (en) Method for purifying polysaccharide iron complex based on ultrafiltration membrane method
CN101708063B (en) Method for concentrating extraction liquid in production of tobacco sheet by papermaking process
CN104119456B (en) Method for separation and purification of edible (medicinal) mushroom active components by multistage membrane process
CN103214533A (en) Method for continuously preparing cordycepin and cordyceps polysaccharide by using membrane separation technology
TW201231673A (en) Method for preparing concentrated aqueous solution of sugar
CN101486794B (en) Preparation method of high antibacterial activity ε-poly-L-lysine component
CN101487034A (en) Preparation f beta-poly malic acid and salt thereof
CN101665448B (en) Method for extracting coronatine from fermentation liquor by using membrane separation technique
WO2022077853A1 (en) Method for extracting grifola frondosa active polysaccharide, and extracted active polysaccharide and use thereof
CN101538593A (en) Method for coupling production of Gamma-polyglutamic acid by technologies of microbial fermentation and membrane separation
CN102432643B (en) Separation method of rhamnolipid by using ultrafiltration membrane
CN101492408A (en) Method for separating tryptophane from fermentation liquor
CN100526333C (en) Method for purifying concentrated polysaccharide of male agaric by using isolation technique of composition filmes
CN103130664A (en) Process method of extracting gamma-aminobutyric acid through membrane separation technique
CN203079886U (en) Large membrane separation integrated resin purification device
CN103830298A (en) Method for preparing panax notoginseng saponins by adopting membrane coupling technology
JP6903622B2 (en) Manufacturing method of red perilla leaf extract
CN101941937A (en) Method for concentrating 5-hydroxytrophan
US20230227487A1 (en) Improved demineralization of fermentation broths and purification of fine chemicals such as oligosaccharides
CN103815405B (en) The production system of cistanche extracts
CN110156853A (en) A method for obtaining high-purity acarbose combined with medium-pressure preparative liquid chromatography
CN106799167A (en) The method that a kind of double films of ultrafiltration/nanofiltration efficiently purify pumpkin oligosaccharide
CN101921343A (en) Method for extracting polysaccharide from fresh hedgehog hydnum
WO2024250372A1 (en) LOW-ENDOTOXIN γ-POLYGLUTAMIC ACID, AND SEPARATION AND EXTRACTION METHOD THEREFOR AND USE THEREOF
CN102812050A (en) Purification method of hyaluronic acid and/or its salt

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: ZHEJIANG SILVER ELEPHANT BIOENGINEERING CO., LTD.

Free format text: FORMER OWNER: TIANJIN UNIVERSITY OF SCIENCE + TECHNOLOGY

Effective date: 20120327

Free format text: FORMER OWNER: YINXIANG BIOLOGICAL ENGINEERING CO., LTD., ZHEJIANG PROV.

Effective date: 20120327

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 300457 HANGU, TIANJIN TO: 317200 TAIZHOU, ZHEJIANG PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20120327

Address after: 317200, Tiantai County, Zhejiang province hi tech Industrial Park, Feng Lu / South Ring Road

Patentee after: ZHEJIANG SILVER-ELEPHANT BIO-ENGINEERING CO., LTD.

Address before: 300457 Tianjin economic and Technological Development Zone, No. thirteenth Main Street, No. 29

Co-patentee before: Yinxiang Biological Engineering Co., Ltd., Zhejiang Prov.

Patentee before: Tianjin University of Science & Technology